Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
47.55
-2.55 (-5.09%)
Mar 9, 2026, 2:51 PM CET

STO:IBT.B Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-65.17-136.91-123.07-65.45-44.99
Upgrade
Other Amortization
0.820.820.820.820.82
Upgrade
Stock-Based Compensation
0.24----
Upgrade
Other Operating Activities
7.04-5.442.07-33-18.85
Upgrade
Change in Accounts Receivable
-2.385.28-9.317.154.34
Upgrade
Change in Other Net Operating Assets
-12.8923.1228.274.693.06
Upgrade
Operating Cash Flow
-72.34-113.13-101.22-85.8-55.62
Upgrade
Other Investing Activities
----0.02-
Upgrade
Investing Cash Flow
----0.02-
Upgrade
Issuance of Common Stock
--101.04--
Upgrade
Other Financing Activities
-2.01-4.521.90.09
Upgrade
Financing Cash Flow
-2.0196.521.90.09
Upgrade
Foreign Exchange Rate Adjustments
7.045.45-2.073318.85
Upgrade
Miscellaneous Cash Flow Adjustments
-14.09-00-0-
Upgrade
Net Cash Flow
-79.38-105.68-6.78-50.91-36.69
Upgrade
Free Cash Flow
-72.34-113.13-101.22-85.8-55.62
Upgrade
Free Cash Flow Margin
--2828325.00%-131453.25%-714958.33%-
Upgrade
Free Cash Flow Per Share
-5.37-8.40-8.19-7.64-4.96
Upgrade
Cash Interest Paid
---0.290.41
Upgrade
Levered Free Cash Flow
-57.33-61.62-64.36-28.66-19.96
Upgrade
Unlevered Free Cash Flow
-57.33-61.62-64.36-28.47-19.71
Upgrade
Change in Working Capital
-15.2728.418.9611.847.4
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.